Nia Emami

Nia Emami is the Chief Scientific Officer and Co-Founder at Bastion Therapeutics, focusing on Autologous & Allogeneic CAR-Treg Therapies for Inflammatory Diseases. Prior to this position, Nia worked as the Director and Founder at Resilient Consulting, specializing in Life Science Consultancy, specifically in Cell Therapies. Nia also has experience as an Associate Director at Quell Therapeutics and Gadeta, working on various therapies for different diseases. Additionally, Nia has a background in research and academia, with experience at King's College London and Barts Cancer Institute. Nia completed a Doctor of Philosophy (PhD) in Immunology from Queen Mary University of London.